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In infertile men, a raised concentration of follicle-stimulating
hormone (FSH) is considered a reliable indicator of germinal
epithelial damage and is usually associated with azoospermia or
severe oligospermia (<5X106 spermatozoa/ml) (Franchimont
et ai, 1972; de Kretser et ai, 1973; Bergmann et ai, 1994).
The elevated FSH concentration is believed to be due to a
decrease in inhibin secretion, which is produced by Sertoli
cells (De Jong and Robertson, 1985). In cases of azoospermia
with high FSH concentrations, a testicular biopsy is believed
to be unnecessary (Hargreave and Jequier, 1978).
The aim of this article is to question all these assertions by
discussing the regulation of FSH secretion in normal and
infertile patients, by reviewing those situations where high
FSH concentrations are associated with normal sperm produc-
tion and by defining the usefulness of testicular biopsies in
some cases of severe oligospermia or azoospermia associated
with high serum FSH concentrations.
Physiological regulation of FSH secretion
FSH is released by the anterior pituitary gland under the
influence of pulsatile secretions of gonadotrophin-releasing
hormone (GnRH). The pituitary response to GnRH is deter-
mined by the frequency and amplitude of the GnRH pulses
and the concentration of gonadal steroids (Finkelstein et ai,
1988). In men with hypogonadotrophic hypogonadism treated
with GnRH, decreasing the pulse frequency of GnRH from
one pulse/hour to one pulse every 3 h, induced an increase of
FSH and of the FSH/luteinizing hormone (LH) ratio (Gross
et al., 1987). This increase may have been due to the slower
metabolic clearance rate of FSH in comparison with LH
(Coble et ai, 1969; Jockenhovel et al., 1990). However, FSH
concentrations remained in the normal range. The dispropor-
tionate rise in serum FSH compared with LH occurred only
in GnRH-deficient men whose testosterone concentrations were
in the hypogonadal range. It was not observed in gonadally
mature patients. This was possibly due either to a normal
concentration of sex steroids or to inhibin secretion by the
mature gonad (Finkelstein et al., 1988). Testosterone is the
most important gonadal regulator of LH and FSH secretion.
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In normal and castrate men, graduated doses of testosterone
produce a dose-dependent inhibition of LH and FSH because
it exerts a negative feedback on the hypothalamus and the
pituitary gland. Most of the gonadotrophin-inhibiting effects
of testosterone can be accounted for by its aromatization into
oestradiol (Snyder and Lawrence, 1980; Valk et al., 1981;
Matsumoto and Bremner, 1984; Finkelstein et ai, 1991).
FSH secretion is also regulated by two non-steroidal
hormones, activin and inhibin, produced by Sertoli cells and
which are also present in the pituitary (Ying, 1988). Inhibin and
activin are dimeric glycoproteins sharing a common P-subunit.
They have antagonistic actions on FSH secretion and have
distinct paracrine actions on the gonads (Saez, 1994). Inhibin
decreases FSH release whereas its secretion is stimulated by
FSH and LH administration (McLachlan et ai, 1988, 1990). In
contrast, activin increases the release of FSH (McLachlan et ai,
1989) and this effect is antagonized by follistatin (Meriggiola
et ai, 1994). Follistatin is a glycoprotein which binds to activin
and modulates its bioavailability (Moore etai, 1994). In elderly
men there is a decrease of basal and clomid-induced inhibin
concentrations in comparison with young men, while serum FSH
concentrations are higher in older men (Tenover et ai, 1988;
MacNaughton et ai, 1991). The decrease in inhibin secretion
may be related to a reduced number of Sertoli cells (Johnson
etai, 1984).
FSH increase in male infertility
In oligospermic men, serum FSH concentrations are usually
normal when the sperm concentration is >10X106/ml. FSH
concentrations are usually above the normal range when sperm
concentration is <5XlO6/ml (de Kretser et ai, 1973; Wu
etai, 1981).
There are at least four possible mechanisms for the selective
elevation of plasma FSH concentrations in men with a
depressed sperm count: (i) the action of a hypothalamic
FSH releasing hormone (activin) distinct from GnRH; (ii) an
alteration in the pattern of GnRH pulses; (iii) a differential
sensitivity of FSH and LH to sex steroid feed-back inhibition;
(iv) inhibin deficiency.
Hypothalamic FSH release of hormone
Activin A has been shown to stimulate basal FSH and GnRH-
stimulated FSH release in adult male primates (Ying, 1988).
However, in the presence of inhibin, the stimulatory effect of
activin is suppressed and it seems improbable that under these
circumstances increased activin concentrations could account
exclusively for FSH increase (Ying, 1988).
Altered patterns of GnRH pulses
A decrease in LH pulse frequency has been observed in some
men with oligospermia and with increased FSH (slow pulsing
oligospermia) (Wagner and Warsch, 1984; Gross et ai, 1985,
1986; Aulitzky et ai, 1989). In these men, pulsatile administra-
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tion of GnRH every 2 h was able to decrease FSH and in
some cases to increase sperm concentration (Wagner and
Warsch, 1984; Gross et ai, 1986; Aulitzky et ai, 1989).
However, these data have not been confirmed by other groups
which observed a normal or an increased LH pulse frequency
(Booth et ai, 1987; Wu et ai, 1989) and a lack of sperm
improvement despite an FSH decrease (Bals-Pratsch et ai,
1989; Bremner et ai, 1993; Wu, 1993).
Several points must be clarified in order to explain these
discrepancies: (i) what is the frequency of LH pulsatility in
normal fertile men? Depending on the frequency of blood
sampling (every 20 or 4 min), 10-30 pulses/24 h have been
recorded (Veldhuis et ai, 1986). In studies measuring LH
every 10 min, a wide range of pulse frequency was found in
normal men, varying between 3 and 19 pulses/24 h (Spratt
et ai, 1968; Veldhuis et ai, 1986). Therefore it is not possible
to diagnose 'slow pulsing oligospermia' if blood is taken every
20 min as in Wagner's study (Wagner and Warsch, 1984); (ii)
is FSH increase due to decreased LH frequency or to decreased
testosterone concentrations? Even if there is an abnormal rise
in serum FSH in GnRH deficient men, when the frequency of
GnRH stimulation is decreased, such changes have not been
found to elevate FSH above the normal range (Gross et ai,
1987; Spratt et ai, 1987). On the other hand, in men with
primary testicular failure, an increased LH pulsatility has been
observed (Matsumoto and Bremner, 1984). In conclusion, if
FSH is still in the normal range a slight increase of the FSH/
LH ratio could point to abnormalities of LH pulsatility,
suggesting a moderate form of hypogonadotrophic hypogonad-
ism which could be successfully treated by pulsatile GnRH
administration (Spratt et ai, 1987). In cases with an abnormally
raised FSH concentration, a primary testicular problem is
almost certain and the efficiency of GnRH treatment remains
to be proven.
Differential sensitivity of FSH and LH to steroid feedback
inhibition
Differential sensitivity of FSH and LH to gonadal steroids is
suspected. Different studies have shown that Leydig cell
function may be altered in men with germinal epithelial injury
and a selective increase in FSH concentration (de Kretser
et ai, 1973; Ruder et ai, 1974; Gross et ai, 1987; Giagulli
and Vermeulen, 1988; Tsatsoulis et ai, 1988; de Kretser et ai,
1989). In such patients, Booth et ai (1987) have shown that
the production rate of testosterone was 50% of that in normal
men but their oestradiol concentrations were normal. Therefore,
the abnormal increase in plasma FSH relative to LH could
result from small decreases in plasma testosterone concentra-
tions. The negative feedback of testosterone is more pro-
nounced on FSH than on LH(Valk etai, 1981). In hypogonadal
men treated with depot testosterone injections at 4 weekly
intervals, an increase of FSH has been observed before a rise
of LH when testosterone fell into the lower normal range
(Snyder and Lawrence, 1980).
Inhibition deficiency
A deficiency of inhibin has been hypothesized. In comparison
with the situation in older men, it has been postulated that a
decrease of inhibin (due to a decreased Sertoli cell function)
would be observed in cases of oligospermia or azoospermia.
However, no (inverse) relationship between serum concentra-
tions of inhibin and FSH has been established in four studies
measuring inhibin in infertile men with azoospermia due to
Klinefelter syndrome, idiopathic or chemotherapy induced
seminiferous tubule damage (Tsatsoulis et ai, 1988; de Kretser
et ai, 1989; Brennemann et ai, 1992; Vicari et ai, 1993). In
most cases of azoospermia, serum concentrations of inhibin did
not differ significantly from normal men. Different explanations
have been given for these unexpected results: (i) inhibin
immunoassays have been developed using antisera or antibod-
ies raised to purified bovine inhibin or to synthetic N-terminal
fragments of the cc-chain. In all these assays, the free a-
subunit, a non-bioactive molecule, cross-reacts with the dimeric
molecule. Therefore the presence of circulating a-subunit
related peptides secreted by the testis could limit the
interpretation of the currently existing inhibin radio-
immunoassay (Schneyer et ai, 1990); (ii) due to Leydig
cell dysfunction in men with severe testicular damage, declining
testosterone could cause an increase of FSH which in turn
would stimulate the Sertoli cells to produce inhibin and
maintain these normal concentrations as long as Sertoli cells
are not altered by the pathologic process; (iii) the possible role
of other FSH modulating substances, such as follistatin or
activin, could also play a role (de Kretser et ai, 1989).
FSH increase with normal sperm production in old patients
Different studies have shown that daily sperm production
declines significantly in older men (Johnson et ai, 1984; Neaves
et ai, 1984; Paniagua et ai, 1987). Although an inverse
relationship has been observed between serum FSH and sperm
production (Neaves etai, 1984), moderate FSH concentrations
in some older men may be able to maintain a normal sperm
concentration. However, high serum FSH concentrations have
been measured in men with involuted testes and reduced or
arrested spermatogenesis (Paniagua et ai, 1987).
Unilateral orchidectomy
An increase in FSH and LH concentrations after unilateral
orchidectomy for testicular cancer has been observed in several
studies (Dunzendorfer and Weber, 1978; Fossa et ai, 1980;
Willemse etai, 1983). However, testicular cancer is frequently
associated with infertility or with the secretion of human
chorionic gonadotrophin (HCG) which can alter endogenous
gonadotrophin concentrations (Berthelsen, 1984).
Increased FSH concentrations (3.7 ± 1.7 mlU/ml) were
found in 22 patients who underwent unilateral orchidectomy
for a benign disease, in comparison with a control group
of 17 fertile men (1.5 ± 0.7 mlU/ml). FSH concentrations
increased from 2.4 to 4.2 mlU/ml and LH concentrations from
2.7 ± 1.2 to 3.2 ± 1.3 mlU/ml when measured in seven
patients before the operation and 10 days to 4 years after
unilateral orchidectomy. There was no significant change in
testosterone concentrations. Sperm analysis performed in 10
cases after unilateral orchidectomy revealed normal sperm
concentrations (>20X106/ml). In three cases with normal
sperm count, FSH was increased to >6.5 mlU/ml (Megevand
et ai, 1985). These results suggest that compensatory FSH
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increase after unilateral orchidectomy could be necessary to
maintain a normal sperm production. This is comparable to
other endorine situations such as an increase in thyroid
stimulating hormone (TSH) in patients with partial thyroidec-
tomy having normal thyroxine concentrations. The FSH
increase after unilateral orchidectomy could be due to decreased
inhibin concentrations according to studies performed in
patients with germinal cancer or in animals (Schanbacher,
1988; Brennemann et ai, 1992).
Compensated spermatogenic failure
A few cases of increased serum FSH concentration associated
with normal seminal parameters have been reported after
mumps, orchitis, orchitis with an atrophic testis and after
cryptorchidism suggesting, as after unilateral orchidectomy,
that an elevated FSH concentration is compatible with relatively
good sperm production and may not necessarily indicate severe
germ cell failure (Wu et ai, 1981; Karpas et ai, 1983).
FSH-secreting pituitary adenoma
In all, 25-30% of pituitary tumours are considered as clinically
nonfunctional (Oppenheim et ai, 1990). However, in four
studies each involving 30-40 men (Snyder, 1985; Beckers
et ai, 1985; Oppenheim et ai, 1990; Lahlou et ai, 1993), it
was reported that 14-43% of all pituitary tumours involved a
hypersecretion of FSH. The majority of these men with
gonadotrophic adenoma did not oversecrete LH and had normal
or subnormal testosterone concentrations (Snyder, 1985). Since
their inhibin concentrations were increased, we must consider
that their FSH was biologically active (Lahlou et ai, 1993).
Sperm analysis, reported in only two of these cases, was
normal (Woolf and Schenk, 1974; Berezin et ai, 1984). Most
of the men with gonadotrophic cell adenoma were middle-
aged men with a history of normal fertility. Examination
showed that they were normally virile, with testes of normal
size. The men had usually sought medical attention because
of visual impairment due to the size of the adenoma
(Snyder, 1985).
Utility of testis biopsy
In cases of azoospermia, associated with small testes and high
FSH concentrations, a testis biopsy is usually considered
unnecessary because FSH elevation is indicative of severe
testicular damage such as Sertoli cell-only syndrome or early
spermatogenic arrest (Hargreave and Jequier, 1978; Jarow
et ai, 1989). However, we wish to discuss several exceptions
to this rule.
Sertoli cell-only syndrome
This condition is characterized by the absence of germinal
epithelium with the unique presence of Sertoli cells, small
seminiferous tubules and small testes (Rothmann et ai, 1982).
Among the 22 cases described by Rothman et ai (1982), eight
had normal FSH concentrations and 14 elevated concentrations,
suggesting the existence of two different types of Sertoli cell-
only syndrome according to FSH concentrations. These data
have been confirmed by several authors (Hargreave and Jequier,
1978; Bergmann et ai, 1994; Turek et ai, 1994). In the
largest series, 88% (69 out of 78 patients) had elevated FSH
concentrations (mean concentration was 3.2 times that of
normal) and 12% (9 out of 78) had normal concentrations
(Turek et ai, 1984). Although elevated FSH concentrations
are considered to result from impaired Sertoli cell function,
the precise nature of this dysfunction remains unknown. No
relationship could be established between the morphological
abnormalities of Sertoli cells and FSH concentrations (de
Kretser et ai, 1981).
Spermatogenic arrest
This condition involves an interruption of the process of germ
cell differentiation leading to the formation of spermatozoa
resulting eventually in azoospermia. It has been observed in
4-30% of testicular biopsies in patients with azoospermia
(Martin-du-Pan and Campana, 1993). There are conflicting
data regarding which stage of spermatogenesis could be related
to the inhibition of FSH production. Some investigators found
an inverse relationship between serum FSH and the number
of spermatogonia (de Kretser et ai, 1973; Martin-du Pan and
Campana, 1993) but normal FSH concentrations in cases of
blockade at the spermatocyte I stage. Other workers have
found elevated FSH concentrations when spermatogenesis was
blocked prior to the spermatid concentration (Franchimont
etai, 1972; Micic, 1983).
These discrepancies could be due to a decrease in the
number of spermatogonia occurring in conjunction with a
decreased number of spermatids (de Kretser et ai, 1973). On
the other hand, the absence of late spermatids in rats was
clearly associated with a marked decrease in the secretion of
inhibin by seminiferous tubules (Allenby et ai, 1991). In man,
the in-vitro production of inhibin by Sertoli cells was decreased
when germ cells were absent (Foucault et ai, 1994). It is well-
known that the various germ cells can specifically modulate
different Sertoli cell functions, confirming the role of sperm-
atids in the regulation of androgen-binding protein, FSH etc.
(Jegou, 1993). From a practical point of view, in cases of
azoospermia with a normal testicular volume and normal FSH
concentrations, a testicular biopsy may be necessary to exclude
spermatogenic arrest, except when immature sperm cells are
present in the ejaculate.
Testis biopsy in azoospermic patients
The use of this procedure in azoospermic men with markedly
elevated FSH concentrations is debated. In cases of azoo-
spermia, if the serum FSH concentration is >three times
normal and if the testes are atrophic, testicular biopsy is
considered unnecessary (Hargrave and Jequier, 1978; Jarow
et ai, 1989). In oligospermic patients, testicular biopsy could
induce a decrease in sperm concentration (Rowley et ai,
1989). However, testicular biopsy has been advocated in cases
of cryptorchidism in order to exclude a carcinoma in situ,
since the risk of testicular cancer is increased four- to five-
fold in that condition, the true prevalence being 2-3%. Of
all patients with testicular cancer, 10% have a history of
cryptorchidism (Giwercman et ai, 1989, 1993). However,
infertility does not represent a severe risk, since in-situ carcin-
oma has been found only in 0.39% of 2043 infertile men and
0.6% of 2739 infertile men (Pryor et ai, 1983; Bettocchi et ai,
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1994). Therefore it is difficult to justify a testicular biopsy for
in-situ carcinoma.
Recently, gamete micromanipulation techniques using testi-
cular sperm obtained by testicular biopsy have resulted in
pregnancies (Schoysman et al., 1993; Devroey et al., 1994).
In most of the cases, testicular biopsy was performed because
of obstructive azoospermia with lack of spermatozoa in the
epididymis. In that situation, serum FSH concentrations are
normal and motile spermatozoa are usually found in the biopsy
(Jow et al., 1993). A recent study has shown that 48% (21
out of 44) azoospermic patients undergoing testicular biopsy
and having FSH concentrations >30 mlU/ml had mature
spermatozoa at the biopsy, whereas 52% (23 out of 44) had
Sertoli cell-only syndrome (Gilbaugh et al., 1994). If these
data are confirmed, they would imply that spermatozoa could
possibly be used for intracytoplasmatic sperm injection (ICSI).
Therefore a testicular biopsy should be discussed and offered
even to azoospermic patients with high FSH concentrations.
This approach would require a genetic analysis of the patient
since it has been found that 15% of azoospermic patients have
abnormal karyotypes (Rivas, 1985).
Conclusion
In conclusion, this article tries to convince the reader
that some current principles in male infertility should be
reconsidered. Firstly, increased concentrations of FSH cannot
be explained exclusively by a decreased inhibin or testosterone.
Other (unknown) factors are probably involved. Secondly, an
elevated FSH concentration does not always indicate a damaged
germinal epithelium but may also reflect a compensatory
adaptation to partial destruction or removal of testicular paren-
chyme, resulting in (sub)normal sperm production. Finally,
testicular biopsies could be useful even in case of azoospermia
with high FSH concentrations because if spermatozoa are
found, they could be used for ICSI.
References
Allenby, C , Foster, P. and Sharpe, R.M. (1991) Evidence that secretion of
immunoactive inhibin by seminiferous tubules from the adult rat testis is
regulated by specific germ cell types: correlation between in vivo and
in vitro studies. Endocrinology, 128, 467-475.
Anapliotou, M.L.G., Liparaki, M., Americanos, N., Goulandris, N. and
Papaioannou, D. (1994) Increased 17-OH-progesterone concentrations
following hCG stimulation in men with idiopathic oligospermia and raised
FSH levels. Int. J. Androi, 17, 192-198.
Aulitzky, W., Frick, J. and Hadziselimovic, F. (1989) Pulsatile LHRH therapy
in patients with oligospermia and disturbed LH pulsatility. Int. J. Androi.,
12, 265-272.
Bals-Pratsch, M., Knuth, U.A., Honigl, W., Klein, H.M., Bergmann, M. and
Nieschlag, E. (1989) Pulsatile Gn-RH-therapy in oligospermic men does
not improve seminal parameters despite decreased FSH levels. J. Clin.
Endocrinol., 30, 549-560.
Beckers, A., Stevenaert, A., Mashiter, K. and Hennen, G. (1985) Follicle-
stimulating hormone-secreting pituitary adenomas. J. Clin. Endocrinol., 61,
525-528.
Bennet, A., Bujan, L., Plantavid, M., Barbe, P., Caron, Ph. and Louvet, J.-P.
(1991) Luteinizing hormone pulse frequency and in vitro bioactivity in
male idiopathic infertility. Fertil. Sterii, 55, 612-618.
Berezin, M., Olchovsky, D., Pines, A., Tadmor, R. and Lunenfeld, B.
(1984) Reduction of follicle-stimulating hormone (FSH) secretion in FSH-
producing pituitary adenoma treated by bromocriptine. J. Clin. Endocrinol.,
59, 1220-1223.
Bergmann, M., Behre. H. and Nieschlag, E. (1994) Serum FSH and testicular
morphology in male infertility. Clin. Endocrinol., 40, 133-136.
Berthelsen, J.G. (1984) Sperm counts and serum follicle-stimulating hormone
concentrations before and after radiotherapy and chemotherapy in men with
testicular germ cell cancer. Fertil. Sterii, 41, 281-285.
Bettochi, C , Coker, C.B., Deacon, J.. Parkinson, C. and Pryor, J. (1994) A
review of testicular intratubular germ cell neoplasia in infertile men. J.
Androi, 15, 14S-16S.
Booth, J.D., Merriam, G.R., Clark, R.V., Loriaux, D.L. and Sherins, (1987)
Evidence for leydig cell dysfunction in infertile men with a selective
increase in plasma follicle-stimulating hormone. J. Clin. Endocr. Metab.,
64, 1194-1198.
Bremner, W.J., Bagatell, C.J., Christensen, R.B. and Matsumoto, A.M. (1993)
Neuroendocrine aspects of the control of gonadotrophin secretion in men.
In Whitcomb, R.W. and Zirkin, B.R. (eds), Understanding Male Infertility.
Serono Symposia Publications no. 98, Raven Press, pp. 29-42.
Brennemann, W., Stoffel-Wagner, B. and Bidlingmaier, F. (1992)
Immunoreactive plasma inhibin levels in men after polyvalent chemotherapy
of germinal cell cancer. Ada Endocrinol., 126, 224—228.
Coble, Y.D., Kohler, P.O., Cargille, CM. and Ross, G.T. (1969) Production
rates and metabolic clearance rates of human follicle-stimulating hormone
in premenopausal and postmenopausal woman. J. Clin. Invest., 48, 359-363.
Cobum, M., Wheeler, T. and Lipshultz, L.I. (1987) Testicular biopsy. Uroi
Clin. N. Am., 14, 551-561.
De Jong, F. and Robertson, D.M. (1985) Inhibin: 1985 update on action and
purification. Mol. Cell., 42, 95-103.
de Kretser, D.M., Burger, H.G. and Hudson, B. (1973) The relationship
between germinal cells and serum FSH levels in males with infertility.
J. Clin. Endocrinol. Metab., 38, 787-793.
de Kretser, D.M., Kerr, J.B. and Paulsen, J.B. (1981) Evaluation of the
ultrastructural changes in the human Sertoli cell in testiscular disorders and
the relationship of the changes to the levels of serum FSH. Int. J. Androi,
4, 129-144.
de Kretser, D.M.. McLachlan, R. and Robertson, D.M. (1989) Serum inhibin
levels in normal men and men with testicular disorders. J. Endocrinol.,
120,517-523.
Devroey, P., Lui, J., Nagy, Z., Tournaye, H., Silbert, S.J. and Van Steirteghem,
A.C. (1994) Normal fertilization of human oocytes after testicular sperm
extraction and intracytoplasmic sperm injection. Fertil. Sterii, 62, 639-641.
Dunzendorfer, U. and Weber, W. (1978) Testosterone, LH and FSH in patients
with treated testicular carcinomas. Harm. Metab., 10, 156-157.
Edwards, R.G., Tarin, J.J., Dean, N., Hirsch, A. and Tan, S.L. (1994) Are
spermatid injections into human oocytes now mandatory? Hum. Reprod.,
9,2217-2219.
Finkelstein, J.S., Badger, T.M., O'Dea, L.S., Spratt, D.I. and Crowley, W.F.
(1988) Effects of decreasing the frequency of gonadotrophin-releasing
hormone stimulation on gonadotropin secretion in gonadotropin releasing
hormone-deficient men and perifused rat pituitary cells. J. Clin. Invest., 81,
1725-1753.
Finkelstein, J.S., Whitcombe, R.W., O'Dea, L.St.L., Longcopes, C ,
Schoenfeld, D.A. and Crowley, W.F. (1991) Sex steroid control of
gonadotropin secretion in the human male. I. Effects of testosterone
administration in normal and gonadotropin-releasing hormone-deficient
men. J. Clin. Endocrinol. Metab., 73, 609-620.
Fishel, S., Green, S., Dowell, K., Thornton, S., McDermott, H., Lisi, F,
Rinaldi, L., Jacobson, M. and Gobetz, L. (1994) Fifty-nine cases of
extreme male factor infertility-immotile spermatozoa, Kartagener syndrome,
globozoospermia, spermatogenic arrest, testicular spermatozoa-treated by
SUZI/ICSI. Hum. Reprod.. 9 (Suppl. 4), 5.
Fossa, S.D., Klepp, O. and Aakvaag, A. (1980) Serum hormone levels in
patients with malignant testicular germ cell tumours without clinical and/
or radiological signs of tumour. Brit. J. Uroi, 52, 151-157.
Foucault, P., Drosdowsky, M.A. and Carreau, S. (1994) Germ cell and Sertoli
cell interactions in human testis: evidence for stimulatory and inhibitory
effects. Hum. Reprod., 9, 2062-2068.
Franchimont, P.D., Millet, E., Vendrely, J., Letawe, J., Legros, J.J. and Netter,
A. (1972) Relationship between spermatogenesis and serum gonadotrophine
levels in azoospermia and oligospermia. J. Clin. Endocrinol., 34,1003—1008.
Giagulli, V.A. and Vermeulen, A. (1988) Leydig cell function in infertile men
with idiopathic oligospermic infertility. J. Clin. Endocrinol. Metab., 66,
62-67.
Gilbaugh, J.H., Patel, V.R., Turek, P.J. and Lipshultz, L.I. (1994) Testis biopsy
findings in azoospermic patients with markedly elevated serum FSH levels.
(Abstr. 0-130) 50th Annual Meeting American Fertility Society, San Antonio,
5-10 November, p. S63.
1943
R.C.Martin-du-Pan and P.Bischof
Giwercman, A., Bruun, E., Frimodt-Moller, C. and Skakkebaek, N.E. (1989)
Prevalence of carcinoma in situ and other histopathological abnormalities
in testes of men with a history of cryptorchidism. J. Urol., 142, 998-1002.
Giwercman, A., von der Maase, H. and Skakkebaek, N.E. (1993)
Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur.
Urol., 23, 104-114.
Gross, K.M., Matsumoto, A.M., Southworth, M.B. and Bremner, W.J. (1985)
Evidence for decreased luteinizing hormone-releasing hormone pulse
frequency in men with selective elevations of follicle-stimulating hormone.
J. Clin. Endocrinol., 60, 197-201.
Gross, KM, Matsumoto, A.M. and Berger, R.E. (1986) Increased frequency of
pulsatile luteinizing hormone-releasing hormone administration selectively
decreases follicle stimulating hormone levels in men with idiopathic
azoospermia. Fertil. Sterii, 45, 392-396.
Gross, K.M., Matsumoto, A.M. and Bremner, W.J. (1987) Differential control
of luteinizing hormone and follicle-stimulating hormone secretion by
luteinizing hormone-releasing hormone pulse frequency in man. J. Clin.
Endocrinol. Metab., 64, 675-671.
Hargreave, T.B. and Jequier, A.M. (1978) Can follicle stimulating hormone
estimation replace testicular biopsy in the diagnosis of obstructive
azoospermia? Br. J. Urol, 50, 415-418.
Jarow, J.P., Espeland, M.A. and Lipshulk, L.I. (1989) Evaluation of the
azoospermic patient. J. Urol, 142, 62-65.
Jegou, B. (1993) The Sertoli-germ cell communication network in mammals.
Int. Rev. Cylol, 147, 25-95.
Jockenhovel, E, Fingscheidt, U., Khan, S.A , Behre, H.M. and Nieschlag, E.
(1990) Bio and immuno-activity of FSH in serum after intramuscular
injection of highly purified urinary human FSH in normal men. Clin.
Endocrinol, 33, 573-584.
Johnson, L., Zane, R.S., Petty, C. and Neaves, W.B. (1984) Quantification of
the human Sertoli cell population: its distribution, relation to germ cell
numbers and age-related decline. Biol. Reprod., 31, 785-790.
Jow, W.W., Steckel, J., Schlegel, P.N., Magid, M.S. and Golsterin, M. (1993)
Motile sperm in human testis biopsy specimens. J. Androl, 14, 194-197.
Karpas, A., Matsumoto, A., Paulsen, C , et al. (1983) Elevated serum follicle-
stimulating hormone levels in men with normal seminal fluid analyses.
Fertil. Sterii, 39, 333-337.
Lahlou, N., Le Nestour, E., Chanson, Ph., Bouchard, P. and Wamet, A. (1993)
Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas:
evidence of a positive correlation with tumour volume in men. Clin.
Endocrinol, 38, 301-309.
McLachlan, R.I., Matsumoto, A.M., Burger, H., de Kretser, D. and Bremner,
W. (1988) Follicle-stimulating hormone is required for quantitatively normal
inhibin secretion in men. J. Clin. Endocrinol. Metab., 67, 1305-1310.
McLachlan, R.I., Dahl, K.D. and Bremner, W.J. (1989) Human recombinant
activin-A stimulates basal FSH and GnRH-stimulated FSH and LH release
in the adult male macaque. Endocrinology, 125, 2787-2789.
McLachlan, R.I., Finkel, D.M., Bremner, W.J. and Snyder, J. (1990) Serum
inhibin concentrations before and during gonadotropin treatment in men with
hypogonadotropic hypogonadism: Physiological and clinical implications.
J. Clin. Endocrinol. Metab., 70, 1414-1419.
MacNaughton, J., Bangah, M.L., McCloud, P.I. and Burger, H. (1991) Inhibin
and age in men. Clin. Endocrinol, 35, 341-346.
Martin-du-Pan, R. and Campana, A. (1993) Physiopathology of spermatogenic
arrest. Fertil. Sterii, 60, 937-946.
Matsumoto, A.M. and Bremner, W.J. (1984) Modulation of pulsatile
gonadotropin secretion by testosterone in man. J. Clin. Endocrinol Metab.,
58,609-613.
Megevand, M., Martin-du-Pan, R. and Bischof, P. (1985) Fonction gonadique
apres orchidectomie pour affection non tumorale. Helv. Chir. Acta, 52,
567-572.
Meriggiola. M.C., Dahl, K D., Mather, J.P. and Bremner, W.J. (1994) Follistatin
decreases activin-stimulated FSH secretion in prepubertal male monkeys.
Endocrinology, 134, 1967-1970.
Micic, S. (1983) The effect of the gametogenesis on serum FSH, LH and
prolactin levels in infertile men. Acta Eur. Fertil, 14, 337-340.
Moore, A., Krummen, L.A. and Mather, J.P. (1994) Inhibins, activins, their
binding proteins and receptors: interactions underlying paracrine activity in
the testis. Mol Cell. Endocrinol, 100, 81-86.
Neaves, W.B., Johnson, L., Porter, J.C., Parker, R. and Petty, C. (1984) Leydig
cell numbers, daily sperm production and serum gonadotropin levels in
aging men. J. Clin. Endocrinol, 55, 756-763.
Oppenheim, D., Kana, A., Sangha, J. and Klibanski, A. (1990) Prevalence
of subunit hypersecretion in patients with pituitary tumors: clinically
nonfunctioning and somatotroph adenomas. J. Clin. Endocrinol,
70, 859-864.
Paniagua, R., Martin, A., Nistal, M., et al. (1987) Testicular involution in
elderly men: comparison of histologic quantitative studies with hormone
patterns. Fertil. Sterii, 47, 671-679.
Pryor, J.P., Cameron, K.M., Cuilton, C.P., Ford, T.F., Parkinson, M.C.,
Sinokrot, J., Westwood, C.A. (1983) Carcinoma in situ in testicular biopsies
from men presenting with infertility. Brit. J. Urol, 55, 780-784.
Rivas, F., Garcia-Esquivel, L., Diaz, M. and Cantu, J.M. (1985) Cytogenetic
evaluation of 163 azoospermics. J. Genet. Hum., 35, 291-298.
Rothmann, CM., Sims, C.A. and Stotts, C.L. (1982) Sertoli cell only
syndrome. Fertil. Sterii, 38, 388-390.
Rowley, M.J., O'Keefe, K.B. and Heller, C.G. (1989) Decreases in sperm
concentration due to testicular biopsy procedure in man. J. Urol, 101,
347-349.
Ruder, H.J., Loriaux, D.L., Sherins, R.J. and Lipsett, M.B. (1974) Leydig cell
function in men with disorders of spermatogenesis. J. Clin. Endocrinol
Metab., 38, 244-247.
Saez, J.M. (1994) Leydig cells: endocrine, paracrine and autocrine regulation.
Endocr. Rev., 15, 574-626.
Schanbacher, B. (1988) Radioimmunoassay of inhibin. Serum response to
unilateral and bilateral orchidectomy. Endocrinology, 123, 2323.
Scheiber, K., Marberger, H. and Bartsch, G. (1983) Exocnne and endocrine
testicular function in patients with unilateral testicular disease. J. R. Soc.
Med., 76, 649-650.
Schneyer, A.L., Mason, A.J., Burton, L.E. and Crowley, W.F. (1990)
Immunoreactive inhibin-subunit in human serum implications for
radioimmunoassay. J. Clin. Endocrinol, 70, 1208-1212.
Schoysman, R, Vanderzwalmen, P., Nijs, M., Segal-Bertin, G., Geerts, L.,
Van Roosendaal, E., Schoysman, D. (1993) Pregnancy after fertilization
with human testicular spermatozoa. Lancet, 342, 1237.
Snyder, P. (1985) Gonadotroph cell adenomas of the pituitary. Endocr. Rev.,
6, 552-563.
Snyder, P.J. and Lawrence, D. (1980) Treatment of male hypogonadism with
testosterone enanthate. J. Clin. Endocrinol. Metab., 51, 1335-1339.
Spratt, D.I., O'Dea, L.St.L., Schoenfeld, D., Butler, J., Rao, N.P. and Crowley
W. (1968) Neuroendocrine-gonadal axis in men: frequent sampling of LH,
FSH and testosterone. J. Physio!., 254, E658-E666.
Spratt, D.I., Carr, D.B., Merriam, G.R., Scully. R.E., Rao, P.N. and Crowley,
W. (1987) The spectrum of abnormal patterns of gonadotropin-releasing
hormone secretion in men with idiopathic hypogonadotropic hypogonadism:
Clinical and laboratory correlations. J. Clin. Endocrinol. Metab., 64,
283-291.
Tenover, J.S., McLachlan, R.I., Dahl, K.D., Burger, H.G., de Kretser, D.M.
and Bremner, A.J. (1988) Decreased serum inhibin levels in normal elderly
men: Evidence for a decline in Sertoli cell function with aging. J. Clin.
Endocrinol. Metab., 67, 455-460.
Tsatsoulis, A., Shalet, S.M., Robertson, W.R., Morris, I.D., Burger, H.G., de
Kretser, D.M. (1988) Plasma inhibin levels in men with chemotherapy-
induced severe damage to the seminiferous epithelium. J. Clin. Endocrinol,
29, 659.
Turek, P.J., Kim, M., Gilbaugh, J.H. and Lipshultz, L.I. (1994) The clinical
characteristics of 78 patients with Sertoli-cell only syndrome. (Abstr.
S63) 50th Annual Meeting American Fertility Society, San Antonio 5-10
November 1994., 0-129.
Valk, T.W., Corley, K.P., Kelch, R.P. and Marshall, J.C. (1981) Pulsatile
gonadotropin-releasing hormone in gonadotropin deficient and normal men:
Suppression of follicle stimulating hormone responses by testosterone. J.
Clin. Endocrinol Metab., 53, 184-191.
Veldhuis, J.D., Rogol, A.D., Evans, W.S., Iranmanesh, A., Lizarralde, G. and
Johnson, M.L. (1986) Spectrum of the pulsatile characteristics of LH release
in normal men. J. Androl, 7, 83-92.
Vicari, E., Calogero, A.E., Burrello, N., Moncada, M.L., Maver, A., Orlando,
C . Vitali. G., Bonaffini, F. and D'Agata, R. (1993) Relationship of inhibin
serum level to bioactive and immunoreactive FSH in oligospermic and
azoospermic patients. Andrologia, 26, 177-184.
Wagner, T. and Warsch, F. (1984) Pulsatile LHRH-therapy of 'slow pulsing
oligospermia': indirect evidence for an hypothalamic origin of the disorder.
Acta Endocrinol. (Suppl.), 264, 142-143.
Willemse. P.H.. Sleijfer. D.T. and Sluiter, W.J. (1983) Altered Leydig cell
function in patients with testicular cancer: evidence for a bilateral testicular
defect. Acta Endocrinol, 102, 616-624
Woolf. P.D. and Schenk, E. (1974) An FSH-producing pituitary tumour in a
patient with hypogonadism. J. Clin. Endocrinol, 38, 561-564.
1944
Increased FSH in infertile men
Wu. F.C.W. (1993) Is male infertility associated with abnormalities in
neuroendocrine GnRH signalling? In Whitcomb. R.W. and Zirkin. B.R.
(eds). International Symposium on Understanding Male Infertility. Serono
Symposia No. 98. Raven Press, pp. 43-54.
Wu. F.C.W., Edmond, P., Raab. G. and Hunter. W.M. (1981) Endocrine
assessment of the subfertile male. J. Clin. Endocrinoi, 14, 493-507.
Wu. F.C.W. Taylor. P.I. and Sellar. R.E. (1989) LHRH pulse frequency in
normal and infertile men. J. Endocrinoi. 123, 149-158.
Ying, S.H. (1988) Inhibins, activins and follistatins: gonadal proteins
modulating the secretion of follicle-stimulating hormone. Endocr. Rev., 9,
267-293.
Whither the investigation of male
infertility? Is FSH measurement
redundant and should all azoospermic
patients have testicular biopsy?
F.C.W.Wu
Department of Medicine, University of Manchester,
Manchester Royal Infirmary and Saint Mary's Hospital,
Manchester, England
Recent reports of decreasing sperm counts and the increasing
prevalence of developmental abnormalities in the male
reproductive tract of Western men have raised the spectre of
a trend of declining male fertility (Carlson et ai, 1992;
Auger et ai, 1995). However, despite the explosion of basic
information on testicular physiology in the last 20 years, the
aetiologies and pathophysiology of defective spermatogenesis
and spermiogenesis underlying the vast majority of patients
suffering from male infertility remain poorly understood.
Recent controlled trials on even relatively well-established
'rational' treatments for specific forms of male infertility such
as immunosuppression for anti-sperm antibodies (Haas and
Manganiello, 1987), ligation or embolization of varicoceles
(Nieschlag et ai, 1994) and antibiotics for genital tract
infections (Yanushpolsky et ai, 1995) have all proved
disappointing. It is therefore exceptional for the clinician to be
in a position to improve impaired semen quality. Consequently,
assisted reproduction technologies (ART) have been
increasingly applied to the empirical management of idiopathic
male infertility, where a sufficient number of motile
spermatozoa can be obtained, even though the results of
treatment have remained relatively poor compared to that
achievable in female infertility. Against this background, the
astounding success recently reported with intracytoplasmic
sperm injection (ICSI) using a single viable spermatozoon
from severely oligozoospermic samples represent a notable
beacon of hope for many patients previously considered beyond
help (Van Steirtegheim et ai, 1993).
The review of Martin-de-Pan and Bischof (1995) is therefore
important beyond the immediate topic addressed by the authors,
namely the utility of follicle stimulating hormone (FSH) and
testicular biospy in the investigation of the infertile male.
It exemplifies the impact that micro-assisted reproduction
technologies are exercising on our current and future approach
to the management of male infertility. Since the establishment
of radioimmunoassays, the measurement of FSH has become
central to the assessment of the infertile male, especially in
those with azoospermia. The main thrust of the review goes
over familiar ground but with a new light which emphasizes
the limitations of FSH measurement as an indirect index
of seminiferous tubular failure. Thus normal FSH cannot
distinguish between obstructive azoospermia and testicular
germ cell arrest. Therefore testicular biopsy and/or microscopic
examination of aspirated epididymal fluid is required. Until
recently, the relatively poor results of conventional in-vitro
fertilization (IVF) using spermatozoa obtained by micro-
epididymal sperm aspiration (MESA) meant that it is not always
appropriate to advise or proceed to an invasive investigation or
expensive procedure for suspected obstructive azoospermia.
However, with the considerably higher fertilization and
implantation rates being reported with ICSI/MESA or the more
simplified method of retrieval by percutaneous epididymal
sperm aspiration (PESA) (Tsirigotis and Craft, 1995), the
prospects for successful treatment in obstructive azoospermia
have been considerably enhanced. A scrotal exploration and
testicular biopsy would now be indicated in most patients
where facilities for ICSI are available.
It has been widely accepted that persistent elevation of
FSH concentration in the presence of azoospermia (especially
associated with bilateral atrophic < 10 ml testes) is synonymous
with extensive and severe primary spermatogenetic failure,
although a minority of seminiferous tubules may still retain
some degree of germ cell development. Testicular biopsy under
these circumstances was deemed unnecessary because of the
lack of treatment and the poor prognosis. However, with the
possibility of successful IVF by ICSI using spermatozoa
retrieved from biopsied seminiferous tubules (Schoysman etai,
1993; Devroey et ai, 1994) even in patients with atrophic
testes and elevated FSH (Silber, 1995; Silber et ai, 1995a),
the latter findings no longer condemn patients with non-
obstructive azoospermia to the alternatives of donor
insemination or adoption. It has been reported that nearly half
(48%) of a group of azoospermic patients with FSH elevated
to three times that of the upper limit of normal has mature
spermatozoa at testicular biopsy (Gilbaugh et ai, 1994). This
is consistent with the rethinking behind the diagnosis of Sertoli
cell-only syndrome where it is now recognized that occasional
foci of spermatozoa can be identified after careful search in
more than half of such cases (Silber, 1995b). Recent reports
of successful fertilization and implantation following
intracytoplasmic injection of round spermatid nuclei (ROSNI)
into rabbit (Sofikitis et ai, 1994) and human oocytes (Sofikitis
et ai, 1995) potentially enhances the scope of treatment even
further to include those patients with spermatogenic arrest,
although it remains unclear whether the paternal centrosome
was donated to the oocyte in this procedure. De Kretser's
group also recently showed that hypergonadotrophic
azoospermia does not rule out the presence of obstructive
lesions and the possibility of fertility (Hauser et ai, 1995).
The upshot of these considerations is that testicular biopsy
should be offered to all azoospermic patients irrespective of
FSH, clearly illustrating how established clinical practice is
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